ArticleJMIR research protocols2022

Intravenous Infusion of Autoserum-Expanded Autologous Mesenchymal Stem Cells in Patients With Chronic Brain Injury: Protocol for a Phase 2 Trial.

Shinichi Oka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.